TRAVERE THERAPEUTICS, INC. (TVTX) Free cash flow 2016–2023
TRAVERE THERAPEUTICS, INC. (TVTX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$280.7MFY2023 · since FY2016: -$4.9M → -$280.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$280.7M | -50.5% |
| FY2022 | -$186.5M | -837.4% |
| FY2021 | -$19.9M | +59.8% |
| FY2020 | -$49.5M | +15.2% |
| FY2019 | -$58.4M | -127.4% |
| FY2018 | -$25.7M | -494.2% |
| FY2017 | $6.5M | +233.8% |
| FY2016 | -$4.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice